Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Onco-Innovations Limited (ONCO.CN)

Onco-Innovations Limited (ONCO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Onco-Innovations' Inka Health Signs New Analytical Work with AstraZeneca Canada to Advance Real-World Evidence in Regulatory Science ACCESS Newswire - Thu Apr 24, 2025

VANCOUVER, BC / ACCESS Newswire / April 24, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly owned subsidiary,...

ONNVF : 1.1000 (-7.56%)
ONCO.CN : 1.4100 (-4.08%)
Onco-Innovations Announces Partnership with Dalton Pharma for Isotope Synthesis of Patented PNKP Technology ACCESS Newswire - Thu Apr 17, 2025

PNKP TechnologyShown in Past Study to Increase Survival Rate in Colorectal Cancer Bearing Mice

ONNVF : 1.1000 (-7.56%)
ONCO.CN : 1.4100 (-4.08%)
Onco-Innovations Announces Private Placement ACCESS Newswire - Wed Apr 16, 2025

Not for distribution to United States wire services or for dissemination in the United States

ONNVF : 1.1000 (-7.56%)
ONCO.CN : 1.4100 (-4.08%)
Onco-Innovations’ Inka Health Publishes Roche-Sponsored Study Advancing Real-World Oncology Research ACCESS Newswire - Thu Apr 10, 2025

VANCOUVER, BC / ACCESS Newswire / April 10, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its subsidiary, Inka...

ONNVF : 1.1000 (-7.56%)
ONCO.CN : 1.4100 (-4.08%)
Onco-Innovations' Inka Health Completes Analytical Work for AstraZeneca Canada, Advancing Pharmaceutical Analytics and Leading to Key Studies at ISPOR 2025 ACCESS Newswire - Thu Apr 3, 2025

VANCOUVER, BC / ACCESS Newswire / April 3, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly owned subsidiary,...

ONNVF : 1.1000 (-7.56%)
ONCO.CN : 1.4100 (-4.08%)
Onco-Innovations' PKNP Technology Used with Radiation Therapy Shown in Study to Demonstrate Low Toxicity and High Safety Profile ACCESS Newswire - Wed Mar 26, 2025

VANCOUVER, BC / ACCESS Newswire / March 26, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to provide information regarding its...

ONNVF : 1.1000 (-7.56%)
ONCO.CN : 1.4100 (-4.08%)
Onco-Innovations Extends Marketing Program ACCESS Newswire - Tue Mar 25, 2025

VANCOUVER, BC / ACCESS Newswire / March 25, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") announces that it has extended the term of its engagement...

ONNVF : 1.1000 (-7.56%)
ONCO.CN : 1.4100 (-4.08%)
Onco-Innovations Provides Update on Use of Proceeds ACCESS Newswire - Mon Mar 24, 2025

VANCOUVER, BC / ACCESS Newswire / March 24, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H), (WKN: A3EKSZ ) (" Onco " or the " Company "), at the request of the Canadian Securities...

ONNVF : 1.1000 (-7.56%)
ONCO.CN : 1.4100 (-4.08%)
Onco-Innovations CEO Thomas O’Shaughnessy Featured on Conversations That Matter to Discuss Breakthroughs in Cancer Treatment, AI Integration, and Potential Global Expansion ACCESS Newswire - Sun Mar 2, 2025

VANCOUVER, BC / ACCESS Newswire / March 2, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt: W1H)(WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that its CEO, Thomas O'Shaughnessy,...

ONCO.CN : 1.4100 (-4.08%)
Onco-Innovations' Inka Health Innovative AI-Driven Oncology Study Paves the Way for New Research ACCESS Newswire - Thu Feb 27, 2025

VANCOUVER, BC / ACCESS Newswire / February 27, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to provide information regarding its...

ONCO.CN : 1.4100 (-4.08%)

Barchart Exclusives

Iran War, CPI and Other Key Thing to Watch this Week Barchart - Sun Mar 8, 12:00PM CDT
Markets enter a critical week following last week's February jobs report that showed the U.S. economy lost around 92,000 jobs, which was a dramatic miss that has intensified recession concerns and raised questions about economic resilience amid escalating geopolitical tensions. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot